United Kingdom· GB-APID-37347611000001103
Ondexxya 200mg powder for solution for infusion vials
A andexanet alfa product containing andexanet alfa, registered in United Kingdom by AstraZeneca UK Ltd. The same ATC class is registered in 12 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Andexanet alfa is registered in 12 of 19 countries.
Countries holding a registration under ATC V03AB38 (andexanet alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Andexanet alfa · ATC V03AB38
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Andexanet alfa
- Manufacturer
- AstraZeneca UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- V03AB38
- ATC class
- Andexanet alfa
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 5
- gtin00369853900814
- gtin05391527740070
- gtin5000456073547
- gtin05000456077736
- gtin05000456077729
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Andexanet alfa in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaONDEXXYAAstraZeneca AB, Södertälje
- SwitzerlandOndexxya 200 mg, Pulver zur Herstellung einer InfusionslösungAstraZeneca AG
- FinlandOndexxyaAstraZeneca AB
- IcelandOndexxyaAstraZeneca AB*
- PolandOndexxyaAstraZeneca AB
- BelgiumOndexxya 200 mgAstraZeneca
- SwedenOndexxya 200 mg Pulver till infusionsvätska, lösningAstraZeneca AB
- SpainONDEXXYA 200 MG POLVO PARA SOLUCION PARA PERFUSIONAstrazeneca Ab
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Ondexxya
- Liechtenstein · Ondexxya
- Norway · Ondexxya
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa3e5356-98ee-43f1-8f4e-664fd0ff9995 GET /v1/drugs/fa3e5356-98ee-43f1-8f4e-664fd0ff9995?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37347611000001103",
"desc": "Ondexxya 200mg powder for solution for infusion vials (AstraZeneca UK Ltd)",
"form": "Powder for solution for infusion",
"vpid": "37454211000001101",
"source": "dmd",
"vtm_id": "783692006",
"strength": "200 mg",
"substance": "Andexanet alfa",
"ingredient": "Andexanet alfa",
"supplier_code": "3583301000001102"
}See everything about andexanet alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.